BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Campbell & CO Investment Adviser LLC's Holding History (CIK: 0001353570)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 68,559 Value ($000) $535 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 109,554 Value ($000) $832 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 412,518 Value ($000) $3,696 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 21,684 Value ($000) $163 Avg Close $8.07 Range $6.96 - $9.50

Q4 2023

Shares 20,702 Value ($000) $124 Avg Close $5.79 Range $4.83 - $7.06

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	68,559	$535	$7.23	$6.00 - $8.17
Q3 2025	109,554	$832	$8.33	$7.42 - $9.23
Q2 2025	412,518	$3,696	$9.31	$6.02 - $11.31
Q1 2025	21,684	$163	$8.07	$6.96 - $9.50
Q4 2023	20,702	$124	$5.79	$4.83 - $7.06